Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "EMA"

3790 News Found

Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru
Hospitals | April 14, 2026

Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru

With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds


AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Clinical Trials | April 14, 2026

AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial

Highlights Mirvetuximab-based regimen promise


Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre
Hospitals | April 14, 2026

Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre

The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy


Max Institute of Cancer Care, Vaishali showcases advanced oncology technologies at ONCO-CON 2026
Hospitals | April 14, 2026

Max Institute of Cancer Care, Vaishali showcases advanced oncology technologies at ONCO-CON 2026

The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care


Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData
News | April 14, 2026

Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData

At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy


India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap
Biopharma | April 13, 2026

India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap

The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness


Orbicular, Apotex win tentative USFDA nod for generic Ozempic
Drug Approval | April 11, 2026

Orbicular, Apotex win tentative USFDA nod for generic Ozempic

Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection


Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
News | April 11, 2026

Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE

Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter


ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer
Hospitals | April 11, 2026

ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer

The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker